Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy

0301 basic medicine Receptors, CXCR4 03 medical and health sciences Lung Neoplasms Tumor Microenvironment Humans Immunotherapy Research Articles B7-H1 Antigen Signal Transduction 3. Good health
DOI: 10.1126/sciadv.aaz9240 Publication Date: 2020-05-15T23:59:07Z
ABSTRACT
CXCR4 antagonistic nanocomplex regulates the immune process to enhance anti–PD-L1 immunotherapy.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (132)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....